Treatment with astragali radix and angelicae radix enhances erythropoietin gene expression in the cyclophosphamide-induced anemic rat

Journal of Medicinal Food

Volumn 12, Issue 3, 2009, Pages 637-642

  Chang, Mun Seog ^a   Kim, Do Rim ^a   Ko, Eun Bit ^a   Choi, Bong Jae ^a   Park, Soo Yeon ^b   Kang, Soon Ah ^c   Park, Seong Kyu ^d  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Seoul University of Venture and Information   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Anemia; Angelicae radix; Astragali radix; Cyclophosphamide; Erythropoietin

Indexed keywords

ANGELICA ROOT; ASTRAGALUS ROOT; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; HERBACEOUS AGENT; MESSENGER RNA; UNCLASSIFIED DRUG;

ANEMIA; ANGELICA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS PLANT; CONTROLLED STUDY; ERYTHROCYTE COUNT; GENE EXPRESSION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ANEMIA; ANGELICA; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTRAGALUS MEMBRANACEUS; BLOOD CELL COUNT; BLOOD CELLS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; ENERGY INTAKE; ERYTHROPOIETIN; GENE EXPRESSION; IRON; MALE; PHYTOTHERAPY; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VITAMIN B 12; WEIGHT GAIN;

RATTUS;

EID: 68149131977     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0727     Document Type: Article

References (27)

1. Borrows R, Loucaidou M, Chusney G, Borrows S, Tromp JV, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D: Anaemia and congestive heart failure early post- renal transplantation. Nephrol Dial Transplant 2008;23:1728- 1734.
2. Iseki K, Kohagura K: Anemia as a risk factor for chronic kidney disease. Kidney Int Suppl 2007;(107):S4-S9.
3. Dimkovic N; Studijske Grupe. [Anemia in patients with diabetes mellitus]. Med Pregl 2007;60:225-230.
4. Gianni L, Cole BF, Panzini I, Snyder R, Holmberg SB, Byrne M, Crivellari D, Colleoni M, Aebi S, Simoncini E, Pagani O, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Ravaioli A: Anemia during adjuvant non-taxane chemotherapy for early breast cancer: incidence and risk factors from two trials of the International Breast Cancer Study Group. Support Care Cancer 2008;16:67-74.
5. Cella D, Dobrez D, Glaspy J: Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol 2003;14:511-519.
6. Smith R: Applications of darbepoietin-alpha, a novel erythropoiesis- stimulating protein, in oncology. Curr Opin Hematol 2002;9:228- 233.
7. Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JWR: Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 2003;21:366-373.
8. Xu ZB, Wu J, Chen HC, Lu YJ, Gong MC: Radix Codonopsis pilosulae and radix Astragali promote erythrocyte glycolysis. Chin Med J (Engl) 1987;100:654-657.
9. Meng H, Zhu MZ, Guo J, Sun JY, Pei JM, Huang C: The study on angiogenesis activity of danggui, chuanxiong and danshen. Zhong Yao Cai 2006;29:574-576.
10. Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M: Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up. Int J Gynecol Cancer 2008;18:803-808.
11. Houssiau F: Thirty years of cyclophosphamide: assessing the evidence. Lupus 2007;16:212-216.
12. Woo S, Krzyzanski W, Jusko WJ: Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chemother Pharmacol 2008;62:123-133.
13. Guide for the Care and Use of Laboratory Animals. NIH publication 78-23. U.S. Department of Health, Education, and Welfare, Bethesda, MD, 1996.
14. Magnanti M, Gandini O, Giuliani L, Gazzaniga P, Marti HH, Gradilone A, Frati L, Aglianò AM, Gassmann M: Erythropoietin expression in primary rat Sertoli and peritubular myoid cell. Blood 2001;98:2872-2874.
15. Hatano R, Takano F, Fushiya S, Michimata M, Tanaka T, Kazama I, Suzuki M, Matsubara M: Water-soluble extracts from Angelica acutiloba Kitagawa enhance hematopoiesis by activating immature erythroid cells in mice with 5-fluorouracil-induced anemia. Exp Hematol 2004;32:918-924.
16. Waters HM, Seal LH: A systematic approach to the assessment of erythropoiesis. Clin Lab Haematol 2001;23:271-283.
17. Horiguchi H, Oguma E, Kayama F: The effects of iron deficiency on estradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related anemia. Blood 2005;106: 67-74.
18. Horiguchi H, Oguma E, Kayama F: Cadmium and cisplatin damage erythropoietin-producing proximal renal tubular cells. Toxicology 2006;80:680-686.
19. Brugnara C: Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003;49:1573-1578.
20. Ebara S, Adachi S, Takenaka S, Enomoto T, Watanabe F, Yamaji R, Inui H, Nakano Y: Hypoxia-induced megaloblastosis in vitamin B12-deficient rats. Br J Nutr 2003;89:441-444.
21. Gunga HC, Kirsch KA, Roecker L, Kohlberg E, Tiedemann J, Steinach M, Schobersberger W: Erythropoietin regulations in humans under different environmental and experimental conditions. Respir Physiol Neurobiol 2007;158:287-297.
22. Spivak JL: Recombinant erythropoietin. Rev Med 1993;44:243-253.
23. Eckardt KU, Ratcliffe PJ, Tan CC, Bauer C, Kurtz A: Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J Clin Invest 1992;89:753-760.
24. Bullard AJ, Govewalla P, Yellon DM: Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 2005;100:397-W3.
25. Nurko S, Spirko R, Law A, Dennis VW: Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: a retrospective cohort study. Clin Ther 2007;29:2010-2021.
26. Kim MO, Kim SH, Shin MJ, Lee DB, Kim TW, Kim KS, Ha JH, Lee S, Park YB, Kim SJ, Ryoo ZY: Human erythropoietin induces lung failure and erythrocytosis in transgenic mice. Mol Cells 2007;23:17-22.
27. Ataka K, Maruyama H, Neichi T, Miyazaki J, Gejyo F: Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Am J Nephrol 2003;23:315-323.